ROS -mediated anticancer response of potent copper(II) drug entities derived from S, O and N, N chelating donor scaffold: Single X-ray crystal diffraction and spectroscopic studies

化学 单斜晶系 结晶学 细胞毒性 三斜晶系 单晶 螯合作用 氧化还原 晶体结构 立体化学 体外 无机化学 生物化学 有机化学
作者
Shariq Yousuf,Farukh Arjmand,Sartaj Tabassum
出处
期刊:Journal of Molecular Structure [Elsevier BV]
卷期号:1262: 132989-132989 被引量:6
标识
DOI:10.1016/j.molstruc.2022.132989
摘要

• The structure of complexes 1 and 2 were thoroughly characterized. • The complexes 1 and 2 were synthesized with an idea of attaining a quick biologically Cu(II)/Cu(I) redox cycle. • The high in vitro cytotoxicity exhibited by five coordinated Cu(II) complex. • Mode of binding of 1 and 2 towards ct-DNA was studied. New Cu(II) anticancer drug entities derived from S, O, and N, N donor chelating scaffolds were synthesized and thoroughly characterized by various spectroscopic and single X-ray diffraction studies. The single X-ray crystal structure of 1 and 2 revealed a monoclinic and triclinic crystal system with space group C 2 / c and P -1, respectively. The biomolecular interaction studies of 1 and 2 with ct-DNA were carried out by employing a battery of biophysical techniques, viz., absorption, emission, circular dichroic, and electrochemical (CV) and corroborative results of these experiments demonstrated avid electrostatic binding via surface groove. The synthesized Cu(II) complexes showed high efficacy as ROS generators involving Cu(II)/Cu(I) redox-active pair as evidenced by cleavage assay in the presence of radical scavengers. The ROS generation in the presence of copper-based complexes is considered one of the most favorable cell death mechanisms for the inhibition of cancers. In vitro anticancer activity of 1 and 2 was, therefore, evaluated against a panel of five human cancer cell lines, namely MCF-7, MDA-MB-231, Hop-62, AW1356, and SiHa, and results of cytotoxicity demonstrated good anticancer response against all tested cancerous strains with GI 50 value <10 µM, except by 1 against MDA-MB-231, Hop-62 and AW1356 cell lines. Interestingly, 2 has displayed considerable cytotoxicity against MCF-7, Hop-62, and SiHa cancer cell lines even better than that of standard drug adriamycin. Furthermore, computational DFT studies validated the high binding efficacy and significant cytotoxicity of complex 2, which could be attributed to high positive charge density over the Cu(II) center. ROS induced DNA damage resulted Cell Death.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
欣喜成仁发布了新的文献求助10
1秒前
Akim应助小张张子采纳,获得10
2秒前
科研通AI6.4应助www采纳,获得10
3秒前
3秒前
科研通AI6.4应助破风采纳,获得10
3秒前
司空博涛发布了新的文献求助10
4秒前
5秒前
一碗淘米水完成签到,获得积分20
6秒前
研友_enPJa8发布了新的文献求助10
6秒前
光华依旧发布了新的文献求助10
8秒前
神勇的长颈鹿完成签到 ,获得积分10
8秒前
Freeasy完成签到,获得积分10
8秒前
yukeshou完成签到 ,获得积分10
8秒前
桐桐应助zuoyou采纳,获得10
8秒前
美好芳完成签到 ,获得积分10
8秒前
10秒前
12秒前
丁丁当当发布了新的文献求助10
12秒前
冷傲含海发布了新的文献求助10
13秒前
可爱的函函应助麻将采纳,获得10
13秒前
啾啾完成签到,获得积分10
13秒前
14秒前
今后应助自由灵雁采纳,获得10
15秒前
qn完成签到,获得积分10
16秒前
福斯卡完成签到 ,获得积分10
16秒前
16秒前
molihuakai应助小泥采纳,获得10
16秒前
脑洞疼应助lin采纳,获得30
17秒前
19秒前
Guang发布了新的文献求助10
19秒前
香蕉觅云应助司空博涛采纳,获得10
20秒前
小马甲应助欣喜成仁采纳,获得10
20秒前
CL完成签到,获得积分10
20秒前
南霖完成签到,获得积分10
20秒前
21秒前
caidan发布了新的文献求助10
22秒前
科研通AI6.2应助勤劳傲安采纳,获得10
24秒前
爆米花应助快乐的冰蓝采纳,获得10
24秒前
24秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Development of a Bridge Weigh-In-Motion System: A technology to convert the bridge response to the passage of traffic into data on vehicle configurations, speeds, times of travel and weights 1000
Molecular Mechanisms of Photosynthesis, 4th Edition 1000
Organic Reactions, Volume 116 1000
Current concepts in cutaneous toxicity : proceedings of the Fourth Conference on Cutaneous Toxicity, Washington, D.C., May 9-11, 1979 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7266833
求助须知:如何正确求助?哪些是违规求助? 8887776
关于积分的说明 18786004
捐赠科研通 6944021
什么是DOI,文献DOI怎么找? 3203219
关于科研通互助平台的介绍 2376149
邀请新用户注册赠送积分活动 2179089